Anders Waage
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Immunology top 1%
- Immune Response and Inflammation
Papers in
- Hematology 164
- Multiple Myeloma Research and Treatments 157
- Immunology 23
- Immune Response and Inflammation 15
- Inflammation biomarkers and pathways 6
- Co-authors
- Terje Espevik (20 shared papers)Alfred Ingvar Halstensen (7 shared papers)Anders Sundan (71 shared papers)Magne Børset (53 shared papers)Peter Kierulf (3 shared papers)Petter Brandtzaeg (2 shared papers)Carina Seidel (15 shared papers)Henrik Hjorth‐Hansen (17 shared papers)
In The Last Decade
Anders Waage
224 papers receiving 15.7k citations
Anders Waage's Hit Papers
Peers
Comparison fields: 5 of 174
- Hematology 7k
- Immunology 1.7k
- Internal Medicine 263
- Microbiology 470
- Oncology 1.4k
Countries citing papers authored by Anders Waage
This map shows the geographic impact of Anders Waage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Waage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Waage more than expected).
Fields of papers citing papers by Anders Waage
This network shows the impact of papers produced by Anders Waage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Waage. The network helps show where Anders Waage may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Waage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. Hit paper breakdown → | 1989 | 1062 |
| 2 | Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma Hit paper breakdown → | 2015 | 1023 |
| 3 | ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE Hit paper breakdown → | 1987 | 969 |
| 4 | Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma Hit paper breakdown → | 2007 | 679 |
| 5 | Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study Hit paper breakdown → | 2011 | 655 |
| 6 | Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. Hit paper breakdown → | 1989 | 414 |
| 7 | 2002 | 332 | |
| 8 | Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project Hit paper breakdown → | 2022 | 303 |
| 9 | Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study Hit paper breakdown → | 2020 | 302 |
| 10 | 2008 | 267 | |
| 11 | 1989 | 255 | |
| 12 | 1993 | 248 | |
| 13 | 2011 | 234 | |
| 14 | 2014 | 232 | |
| 15 | 1988 | 221 | |
| 16 | Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group Hit paper breakdown → | 2021 | 211 |
| 17 | 2010 | 205 | |
| 18 | 1990 | 204 | |
| 19 | 2000 | 204 | |
| 20 | Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. | 1988 | 201 |
About Anders Waage
Anders Waage is a scholar working on Hematology, Immunology, Oncology, Microbiology and Epidemiology, having authored 232 papers that have together received 16.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (157 papers), Immune Response and Inflammation (15 papers), Sepsis Diagnosis and Treatment (12 papers), Bacterial Infections and Vaccines (8 papers), Inflammation biomarkers and pathways (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), TGF-β signaling in diseases (5 papers) and Bone Metabolism and Diseases (5 papers). The work is most often cited by research in Hematology (7k citations), Immunology (1.7k citations), Internal Medicine (263 citations), Microbiology (470 citations) and Oncology (1.4k citations). Anders Waage has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Terje Espevik, Alfred Ingvar Halstensen, Anders Sundan, Magne Børset, Peter Kierulf, Petter Brandtzaeg, Carina Seidel, Henrik Hjorth‐Hansen, Refaat Shalaby and Øyvind Hjertner. Their work appears in journals such as Blood, British Journal of Haematology, European Journal Of Haematology, Blood Cancer Journal and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.